Biogen Idec, Inc. (Massachusetts) Surpasses $5 Billion in 2011 Annual Revenue

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its full year and fourth quarter 2011 results.